vs
Astrana Health, Inc.（ASTH）与BrightView Holdings, Inc.（BV）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是BrightView Holdings, Inc.的1.4倍（$950.5M vs $702.9M），Astrana Health, Inc.净利率更高（0.7% vs 0.2%，领先0.4%），Astrana Health, Inc.同比增速更快（42.9% vs 6.1%），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -1.8%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
BrightView Holdings是美国领先的商业景观服务提供商，业务涵盖景观设计、施工、日常养护、灌溉系统管理、除雪除冰等，服务客户覆盖企业园区、商业中心、住宅社区及公共部门等场景。
ASTH vs BV — 直观对比
营收规模更大
ASTH
是对方的1.4倍
$702.9M
营收增速更快
ASTH
高出36.8%
6.1%
净利率更高
ASTH
高出0.4%
0.2%
两年增速更快
ASTH
近两年复合增速
-1.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $702.9M |
| 净利润 | $6.6M | $1.7M |
| 毛利率 | — | 19.6% |
| 营业利润率 | 1.9% | 2.3% |
| 净利率 | 0.7% | 0.2% |
| 营收同比 | 42.9% | 6.1% |
| 净利润同比 | 184.4% | -73.4% |
| 每股收益（稀释后） | $0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHBV
| Q2 26 | — | $702.9M | ||
| Q1 26 | — | $614.7M | ||
| Q4 25 | $950.5M | $614.7M | ||
| Q3 25 | $956.0M | $702.7M | ||
| Q2 25 | $654.8M | $708.3M | ||
| Q1 25 | $620.4M | $662.6M | ||
| Q4 24 | $665.2M | $599.2M | ||
| Q3 24 | $478.7M | $728.7M |
净利润ASTHBV
| Q2 26 | — | $1.7M | ||
| Q1 26 | — | — | ||
| Q4 25 | $6.6M | $-15.2M | ||
| Q3 25 | $373.0K | $27.7M | ||
| Q2 25 | $9.4M | $32.3M | ||
| Q1 25 | $6.7M | $6.4M | ||
| Q4 24 | $-7.8M | $-10.4M | ||
| Q3 24 | $16.1M | $25.6M |
毛利率ASTHBV
| Q2 26 | — | 19.6% | ||
| Q1 26 | — | 18.6% | ||
| Q4 25 | — | 18.6% | ||
| Q3 25 | — | 25.1% | ||
| Q2 25 | — | 24.1% | ||
| Q1 25 | — | 22.3% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | — | 25.0% |
营业利润率ASTHBV
| Q2 26 | — | 2.3% | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | -1.2% | ||
| Q3 25 | 2.0% | 7.9% | ||
| Q2 25 | 3.1% | 8.1% | ||
| Q1 25 | 3.3% | 3.4% | ||
| Q4 24 | 0.1% | -0.1% | ||
| Q3 24 | 5.9% | 7.1% |
净利率ASTHBV
| Q2 26 | — | 0.2% | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | -2.5% | ||
| Q3 25 | 0.0% | 3.9% | ||
| Q2 25 | 1.4% | 4.6% | ||
| Q1 25 | 1.1% | 1.0% | ||
| Q4 24 | -1.2% | -1.7% | ||
| Q3 24 | 3.4% | 3.5% |
每股收益（稀释后）ASTHBV
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $0.12 | $-0.26 | ||
| Q3 25 | $0.01 | $0.21 | ||
| Q2 25 | $0.19 | $0.15 | ||
| Q1 25 | $0.14 | $-0.03 | ||
| Q4 24 | $-0.14 | $-0.20 | ||
| Q3 24 | $0.33 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $10.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | — |
| 总资产 | $2.2B | $3.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHBV
| Q2 26 | — | $10.1M | ||
| Q1 26 | — | $37.0M | ||
| Q4 25 | $429.5M | $37.0M | ||
| Q3 25 | $463.4M | $74.5M | ||
| Q2 25 | $342.1M | $79.1M | ||
| Q1 25 | $260.9M | $141.3M | ||
| Q4 24 | $290.8M | $98.3M | ||
| Q3 24 | $350.3M | $140.4M |
总债务ASTHBV
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $801.1M | ||
| Q3 25 | — | $790.2M | ||
| Q2 25 | — | $790.7M | ||
| Q1 25 | — | $798.9M | ||
| Q4 24 | — | $796.5M | ||
| Q3 24 | — | $802.5M |
股东权益ASTHBV
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $779.3M | $1.3B | ||
| Q3 25 | $775.5M | $1.3B | ||
| Q2 25 | $765.5M | $1.3B | ||
| Q1 25 | $745.4M | $1.3B | ||
| Q4 24 | $712.7M | $1.3B | ||
| Q3 24 | $704.6M | $1.3B |
总资产ASTHBV
| Q2 26 | — | $3.4B | ||
| Q1 26 | — | $3.3B | ||
| Q4 25 | $2.2B | $3.3B | ||
| Q3 25 | $2.2B | $3.4B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.3B | $3.3B | ||
| Q4 24 | $1.4B | $3.3B | ||
| Q3 24 | $1.3B | $3.4B |
负债/权益比ASTHBV
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.64× | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 0.63× | ||
| Q4 24 | — | 0.63× | ||
| Q3 24 | — | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $82.3M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | 7.8% |
| 现金转化率经营现金流/净利润 | -0.44× | 48.41× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHBV
| Q2 26 | — | $82.3M | ||
| Q1 26 | — | $36.1M | ||
| Q4 25 | $-2.9M | $36.1M | ||
| Q3 25 | $10.0M | $84.4M | ||
| Q2 25 | $90.9M | $55.7M | ||
| Q1 25 | $16.6M | $91.2M | ||
| Q4 24 | $-10.9M | $60.5M | ||
| Q3 24 | $34.0M | $53.5M |
自由现金流ASTHBV
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $-18.6M | ||
| Q3 25 | $7.4M | $26.0M | ||
| Q2 25 | $89.5M | $-47.8M | ||
| Q1 25 | $13.6M | $57.6M | ||
| Q4 24 | $-13.5M | $1.8M | ||
| Q3 24 | $31.7M | $21.1M |
自由现金流率ASTHBV
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | -3.0% | ||
| Q3 25 | 0.8% | 3.7% | ||
| Q2 25 | 13.7% | -6.7% | ||
| Q1 25 | 2.2% | 8.7% | ||
| Q4 24 | -2.0% | 0.3% | ||
| Q3 24 | 6.6% | 2.9% |
资本支出强度ASTHBV
| Q2 26 | — | 7.8% | ||
| Q1 26 | — | 7.9% | ||
| Q4 25 | 0.3% | 8.9% | ||
| Q3 25 | 0.3% | 8.3% | ||
| Q2 25 | 0.2% | 14.6% | ||
| Q1 25 | 0.5% | 5.1% | ||
| Q4 24 | 0.4% | 9.8% | ||
| Q3 24 | 0.5% | 4.4% |
现金转化率ASTHBV
| Q2 26 | — | 48.41× | ||
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 3.05× | ||
| Q2 25 | 9.65× | 1.72× | ||
| Q1 25 | 2.48× | 14.25× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 2.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BV
暂无分部数据
